TAG ARCHIVE
POSTS TAGGED AS signal transduction pathway
Maintaining Pluripotency in hESC’s
March 4, 2014 | Terry Sharrer | Posted in Newsletter
hESCs
Since 2001, when the USFDA approved “Gleevec” for clinical use, scientists, oncologists and cancer patients alike have understood “signal induction [MORE]
